Recommendations of the National Advisory Committee on Immunization (NACI) on Extended Dose Intervals for COVID-19 Vaccines

Introduction

This moderated and live webinar includes a presentation, discussion and Q & A on the National Advisory Committee on Immunization (NACI) recommendations on Extended Dose Intervals and Effectiveness of COVID-19 Vaccines.

The National Collaborating Centre for Infectious Diseases presents:

The Public Health Agency of Canada (PHAC) COVID-19 Vaccines Webinar for Health Care Providers to inform health care and vaccine providers on topics for discussion on COVID-19 vaccines.

This moderated and live webinar includes a presentation, discussion and Q & A on the National Advisory Committee on Immunization (NACI) recommendations on Extended Dose Intervals and Effectiveness of COVID-19 Vaccines.

Resources

English Presentation

Wednesday, May 5, 2021

1:00-2:00 pm EDT

Presentation highlights:

  • To provide a brief overview of NACI guidance in the context of public health decision making
  • To describe the efficacy and effectiveness of COVID-19 vaccines in the context of one or two doses
  • To discuss the impacts of extended dose intervals of COVID-19 vaccines
  • To present the NACI recommendations on extended dose intervals

Moderator:

Dr. April Killikelly, PhD, Public Health Agency of Canada

Presenters:

Dr. Robyn Harrison, MD, National Advisory Committee on Immunization

Dr. Jesse Papenburg, MD, National Advisory Committee on Immunization

Dr. Bryna Warshawsky, MD, Public Health Agency of Canada

Dr. Austin Nam, MSc, PhD, Public Health Agency of Canada

Dr. Beate Sander, RN MBA MEcDev PhD, National Advisory Committee on Immunization